Jane Street’s Nautilus Biotechnolgy NAUT Stock Holding History

Jane Street’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,000	Closed	-$92K	–	10577
2021 Q3	$92K	Buy	+15,000	New	+$120K	﹤0.01%	9339

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Jane Street's NAUT Position: Q2 2026 in Review

Jane Street sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 61,802 shares — an estimated $240K sold.

Jane Street first reported a position in NAUT in Q1 2021 and held it in 19 quarters. The position peaked at $2.65M in Q1 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Jane Street reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
Jane Street sold 61,802 Nautilus Biotechnolgy shares in Q2 2026, an estimated $240K.
Jane Street first reported a position in Nautilus Biotechnolgy in Q1 2021 and held it in 19 quarters.
Jane Street's Nautilus Biotechnolgy position peaked at $2.65M in Q1 2021.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.